# Innate Pharma SA: Form 6-K, filed Sep 2, 2026

- Company: [Innate Pharma SA](/companies/ipha.md) (CIK 1598599)
- Form: 6-K
- Filed: 2026-09-02
- Accepted by EDGAR: Sep 2, 2026, 06:56 ET
- Period: 2026-09-02
- Accession: 0001628280-26-059963
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1598599/000162828026059963/a260902_6k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1598599/000162828026059963/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1598599/000162828026059963/a260902_6k.htm

Filed Sep 2, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-059963. Last ingested by Listed: Oct 27, 2026, 07:14 ET. No prices; not investment advice.